Evidence map›Paper›PMID 34321045›Full record

ArticleHealth and quality of life outcomes2021

Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods.

Pascal Amedro, Oscar Werner, Hamouda Abassi, Aymeric Boisson, Luc Souilla, Sophie Guillaumont, Johanna Calderon, Anne Requirand, Marie Vincenti, Victor Pommier and 18 more

3 registry-linked trialsOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Health and quality of life outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04712136 nacompletednot on this map

Healthy-related Quality of Life and Physical Activity of Children With Inherited Cardiac Arrhythmia or Inherited Cardiomyopathies: the Prospective Multicentre Controlled QUALIMYORYTHM Study

TypeinterventionalSponsorUniversity Hospital, MontpellierRan2021 to 2023Enrolled214ConditionsLong QT Syndrome, Brugada Syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia, Arrhythmogenic Right Ventricular DysplasiaArmsMRI
NCT05670132 narecruitingnot on this mapstarted 2024, after this paper: background citation

Impact of a Neuro-cardiac Rehabilitation Program on the Quality of Life of Children, Adolescents, and Young Adults With Congenital Heart Disease: the Multicentre Randomized Controlled QUALINEUROREHAB Trial

TypeinterventionalSponsorUniversity Hospital, BordeauxRan2024 to 2028Enrolled192ConditionsCongenital Heart DiseaseArmsNeurocardiac rehabilitation program, Standard of care
NCT05964322 completednot on this mapstarted 2022, after this paper: background citation

Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome

TypeobservationalSponsorUniversity Hospital, MontpellierRan2022 to 2024Enrolled8ConditionsLong QT Syndrome, Congenital Long Qt Syndrome, Inherited Cardiac Conduction Disorder, Pediatric ALL
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Sports or no sports? How to manage the young arrhythmia patient.Herzschrittmachertherapie & Elektrophysiologie · 2025
    Review
  4. Brugada Syndrome and Exercise: Is It Time for a Paradigm Change?Journal of cardiovascular development and disease · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 4 countries.

Pascal AmedroDepartment of Paediatric and Adult Congenital Cardiology, M3C National Reference Centre, Haut-Lévêque Cardiology Hospital, Bordeaux University Hospital, Avenue de Magellan, 33604, Pessac Cedex, France. pascal.amedro@gmail.com.ORCID http://orcid.org/0000-0003-3649-0294
Oscar WernerPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Hamouda AbassiPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Aymeric BoissonPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Luc SouillaPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Sophie GuillaumontPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Johanna CalderonPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Anne RequirandPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Marie VincentiPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Victor PommierPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Stefan MateckiPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Gregoire De La VilleonPaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Kathleen LavastrePaediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
Alain LacampagnePhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
Marie-Christine PicotEpidemiology and Clinical Research Department, Montpellier University Hospital, Montpellier, France.
Constance BeylerPaediatric Cardiology and Physiology Department, Robert Debré University Hospital, University of Paris, AP-HP, Paris, France.
Christophe DelclauxPaediatric Cardiology and Physiology Department, Robert Debré University Hospital, University of Paris, AP-HP, Paris, France.
Yves DulacPaediatric Cardiology Department, M3C Regional Reference Centre, Toulouse University Hospital, Toulouse, France.
Aitor GuitartePaediatric Cardiology Department, M3C Regional Reference Centre, Toulouse University Hospital, Toulouse, France.
Philippe CharronDepartment of Cardiology, National Reference Centre for Inherited Cardiomyopathy, University of Paris, AP-HP, Paris, France.
Isabelle Denjoy-UrbainDepartment of Cardiology, National Reference Centre for Inherited Cardiomyopathy, University of Paris, AP-HP, Paris, France.
Vincent ProbstDepartment of Cardiology, National Reference Centre for Inherited Cardiac Arrhythmia, L'institut du thorax, INSERM, CNRS, University of Nantes, Nantes University Hospital, Nantes, France.
Alban-Elouen BaruteauDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, L'Institut du Thorax, INSERM, CNRS, University of Nantes, Nantes University Hospital, Nantes, France.
Philippe ChevalierDepartment of Congenital Cardiology, National Reference Centre for Inherited Cardiac Arrhythmia, University of Lyon, Lyon University Hospital, Lyon, France.
Sylvie Di FilippoDepartment of Congenital Cardiology, National Reference Centre for Inherited Cardiac Arrhythmia, University of Lyon, Lyon University Hospital, Lyon, France.
Jean-Benoit ThamboDepartment of Paediatric and Adult Congenital Cardiology, M3C National Reference Centre, Haut-Lévêque Cardiology Hospital, Bordeaux University Hospital, Avenue de Magellan, 33604, Pessac Cedex, France.
Damien BonnetPaediatric Cardiology Department, Necker-Enfants malades, M3C National Reference Centre, University of Paris, AP-HP, Paris, France.
Jean-Luc PasquieCardiology Department of Cardiology, Regional Reference Centre for Inherited Cardiac Arrhythmia, Montpellier University Hospital, Montpellier, France.
Université de Montpellier · FRCentre National de la Recherche Scientifique · FRUniversité Paris Cité · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Bordeaux · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRHôpital Necker-Enfants Malades · FR

Funding

Cardiogen 2018 Call for proposalCentre Hospitalier Régional Universitaire de Montpellier AOI 2019 young researcher awardDirection Générale de l'offre de Soins GIRCI-SOHO-APITHEM-2019Fédération Française de Cardiologie AAP FFC 2019
6 · The paper itself

Abstract

backgroundAdvances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial.

methodsThe QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease's clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%. DISCUSSION: After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population. Trial registration ClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 ( https://clinicaltrials.gov/ct2/show/NCT04712136 ).

Indexed as

Arrhythmias, CardiacCardiomyopathiesExerciseQuality of LifeAdolescentChildDeath, Sudden, CardiacFemaleHumansMaleMulticenter Studies as TopicNon-Randomized Controlled Trials as TopicOxygenOxygen ConsumptionProspective StudiesOxygenGenetic cardiomyopathyInherited cardiac arrhythmiaPaediatricsPhysical activityQuality of life

Identifiers

PMID34321045
PMCPMC8317438
OpenAlexW3153210240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.